Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C2 | P08235 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ANPEP | P15144 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.35 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.35 |
| ▸ | CTSL | P07711 | 1/20 | 0.35 |
| ▸ | CTSB | P07858 | 1/20 | 0.35 |
| ▸ | CTSS | P25774 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953498 | 0.93 | NR3C2 (0.38) | NR3C2ATMCYP1A2MEN1KMT2A | |
| SCHEMBL30953276 | 0.88 | AAK1 (0.44) | NR3C2MAPK13LMNARAB9A | |
| SCHEMBL30953268 | 0.87 | NR3C2 (0.42) | NR3C2ATMCYP1A2MEN1KMT2A | |
| SCHEMBL30953507 | 0.82 | ANPEP (0.40) | NR3C2CYP1A2ANPEPCTSKCTSL | |
| SCHEMBL30953479 | 0.81 | ANPEP (0.39) | NR3C2ATMCYP1A2MEN1KMT2A | |
| SCHEMBL30953499 | 0.80 | AAK1 (0.39) | NR3C2ATMCTSLKDM4E | |
| SCHEMBL30953283 | 0.79 | NR3C2 (0.42) | NR3C2ATMCYP1A2MEN1KMT2A | |
| SCHEMBL30953303 | 0.79 | NR3C2 (0.42) | NR3C2ATMCYP1A2MEN1KMT2A | |
| SCHEMBL30953316 | 0.78 | AAK1 (0.44) | MEN1KMT2ACTSLCTSSLMNA | |
| SCHEMBL30953293 | 0.78 | AAK1 (0.41) | NR3C2MAPK13LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |